EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review

Hamid Motamedi, Marzie Mahdizade Ari, Amirhoushang Alvandi, Ramin Abiri

Frontiers in Microbiology · 13.06.2024 · 15

DOI: 10.3389/fmicb.2024.1393646 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.06.2024. Verfasst von Hamid Motamedi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While significant progress has been made in understanding and applying gene silencing mechanisms and the treatment of human diseases, there have been still several obstacles in therapeutic use. For the first time, ONPATTRO, as the first small interfering RNA (siRNA) based drug was invented in 2018 for treatment of hTTR with polyneuropathy. Additionally, four other siRNA based drugs naming Givosiran, Inclisiran, Lumasiran, and Vutrisiran have been approved by the US Food and Drug Administration and the European Medicines Agency for clinical use by hitherto. In this review, we have discussed the key and promising advances in the development of siRNA-based drugs in preclinical and clinical stages, the impact of these molecules in bacterial and viral infection diseases, delivery system issues, the impact of administration methods, limitations of siRNA application and how to overcome them and a glimpse into future developments.

Schlagwörter

Stichwörter der Autor:innen

RNAidelivery systemsnon-coding RNAsiRNAtherapeutic applications

Autor:innen und Institutionen

  • Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Microbial Biotechnology Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Medical Technology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Zitieren

APA

Motamedi, H., Ari, M. M., Alvandi, A., & Abiri, R. (2024). Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1393646

Vancouver

Motamedi H, Ari MM, Alvandi A, Abiri R. Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1393646

BibTeX
@article{Motamedi2024,
  author = {Motamedi, Hamid and Ari, Marzie Mahdizade and Alvandi, Amirhoushang and Abiri, Ramin},
  title = {Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1393646}
}
Kostenlos starten →